Trial intelligence / Profile preview

Remimazolam vs propofol for sedation in painless abortion

ChiCTR2000034121Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of Guizhou Medical University
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: MOAA/S sedation score. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2000034121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call